Dengue Vaccine (Tetravalent Live Attenuated) from Canada
Dengvaxia chimeric yellow fever-dengue tetravalent live vaccine for seropositive individuals. Under HTS 3002.49.00 as 'other' vaccines from micro-organisms. Three-dose schedule over 12 months.
Duty Rate — Canada → United States
0%
Rate breakdown
9903.05.860%Universal product exemption (U.S. note 52(b))
Import Tips
• Screen recipients for prior dengue exposure per label
• Maintain 2-8°C chain with validated shippers
• Avoid classification as research virus stock